Literature DB >> 34532824

Diagnostic Considerations in the Epilepsies-Testing Strategies, Test Type Advantages, and Limitations.

Wei-Liang Chen1, Heather C Mefford2,3.   

Abstract

The role of genetics in epilepsy has been recognized for a long time. Over the past decade, genome-wide technologies have identified numerous genes and variants associated with epilepsy. In the clinical setting, a myriad of genetic testing options are available, and a subset of specific genetic diagnoses have management implications. Furthermore, genetic testing can be a dynamic process. As a result, fundamental knowledge about genetics and genomics has become essential for all specialists. Here, we review current knowledge of the genetic contribution to various types of epilepsy, provide an overview of types of genetic variants, and discuss genetic testing options and their diagnostic yield. We also consider advantages and limitations of testing approaches.
© 2021. The American Society for Experimental NeuroTherapeutics, Inc.

Entities:  

Keywords:  Chromosome microarray; Exome sequencing; Gene panel; Genetic epilepsy; Inheritance pattern

Mesh:

Year:  2021        PMID: 34532824      PMCID: PMC8608977          DOI: 10.1007/s13311-021-01121-7

Source DB:  PubMed          Journal:  Neurotherapeutics        ISSN: 1878-7479            Impact factor:   6.088


  65 in total

Review 1.  Copy number variants are frequent in genetic generalized epilepsy with intellectual disability.

Authors:  Saul A Mullen; Gemma L Carvill; Susannah Bellows; Marta A Bayly; Holger Trucks; Dennis Lal; Thoman Sander; Samuel F Berkovic; Leanne M Dibbens; Ingrid E Scheffer; Heather C Mefford
Journal:  Neurology       Date:  2013-09-25       Impact factor: 9.910

2.  Diagnostic yield of targeted massively parallel sequencing in children with epileptic encephalopathy.

Authors:  Kavitha Kothur; Katherine Holman; Elizabeth Farnsworth; Gladys Ho; Michelle Lorentzos; Christopher Troedson; Sachin Gupta; Richard Webster; Peter G Procopis; Manoj P Menezes; Jayne Antony; Simone Ardern-Holmes; Russell C Dale; John Christodoulou; Deepak Gill; Bruce Bennetts
Journal:  Seizure       Date:  2018-05-28       Impact factor: 3.184

3.  De novo mutations in synaptic transmission genes including DNM1 cause epileptic encephalopathies.

Authors: 
Journal:  Am J Hum Genet       Date:  2014-09-25       Impact factor: 11.025

4.  Diagnostic outcomes for genetic testing of 70 genes in 8565 patients with epilepsy and neurodevelopmental disorders.

Authors:  Amanda S Lindy; Mary Beth Stosser; Elizabeth Butler; Courtney Downtain-Pickersgill; Anita Shanmugham; Kyle Retterer; Tracy Brandt; Gabriele Richard; Dianalee A McKnight
Journal:  Epilepsia       Date:  2018-04-14       Impact factor: 5.864

5.  Copy number variation plays an important role in clinical epilepsy.

Authors:  Heather Olson; Yiping Shen; Jennifer Avallone; Beth R Sheidley; Rebecca Pinsky; Ann M Bergin; Gerard T Berry; Frank H Duffy; Yaman Eksioglu; David J Harris; Fuki M Hisama; Eugenia Ho; Mira Irons; Christina M Jacobsen; Philip James; Sanjeev Kothare; Omar Khwaja; Jonathan Lipton; Tobias Loddenkemper; Jennifer Markowitz; Kiran Maski; J Thomas Megerian; Edward Neilan; Peter C Raffalli; Michael Robbins; Amy Roberts; Eugene Roe; Caitlin Rollins; Mustafa Sahin; Dean Sarco; Alison Schonwald; Sharon E Smith; Janet Soul; Joan M Stoler; Masanori Takeoka; Wen-Han Tan; Alcy R Torres; Peter Tsai; David K Urion; Laura Weissman; Robert Wolff; Bai-Lin Wu; David T Miller; Annapurna Poduri
Journal:  Ann Neurol       Date:  2014-06-13       Impact factor: 10.422

6.  Familial risk of epilepsy: a population-based study.

Authors:  Anna L Peljto; Christie Barker-Cummings; Vincent M Vasoli; Cynthia L Leibson; W Allen Hauser; Jeffrey R Buchhalter; Ruth Ottman
Journal:  Brain       Date:  2014-01-26       Impact factor: 13.501

7.  A missense mutation in the neuronal nicotinic acetylcholine receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy.

Authors:  O K Steinlein; J C Mulley; P Propping; R H Wallace; H A Phillips; G R Sutherland; I E Scheffer; S F Berkovic
Journal:  Nat Genet       Date:  1995-10       Impact factor: 38.330

8.  Deletions of 16p11.2 and 19p13.2 in a family with intellectual disability and generalized epilepsy.

Authors:  Alexander G Bassuk; Eileen Geraghty; Shu Wu; Saul A Mullen; Samuel F Berkovic; Ingrid E Scheffer; Heather C Mefford
Journal:  Am J Med Genet A       Date:  2013-05-17       Impact factor: 2.802

Review 9.  Primer Part 1-The building blocks of epilepsy genetics.

Authors:  Ingo Helbig; Erin L Heinzen; Heather C Mefford
Journal:  Epilepsia       Date:  2016-05-25       Impact factor: 5.864

10.  De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes.

Authors:  Jean-Baptiste Rivière; Ghayda M Mirzaa; Brian J O'Roak; Margaret Beddaoui; Diana Alcantara; Robert L Conway; Judith St-Onge; Jeremy A Schwartzentruber; Karen W Gripp; Sarah M Nikkel; Thea Worthylake; Christopher T Sullivan; Thomas R Ward; Hailly E Butler; Nancy A Kramer; Beate Albrecht; Christine M Armour; Linlea Armstrong; Oana Caluseriu; Cheryl Cytrynbaum; Beth A Drolet; A Micheil Innes; Julie L Lauzon; Angela E Lin; Grazia M S Mancini; Wendy S Meschino; James D Reggin; Anand K Saggar; Tally Lerman-Sagie; Gökhan Uyanik; Rosanna Weksberg; Birgit Zirn; Chandree L Beaulieu; Jacek Majewski; Dennis E Bulman; Mark O'Driscoll; Jay Shendure; John M Graham; Kym M Boycott; William B Dobyns
Journal:  Nat Genet       Date:  2012-06-24       Impact factor: 38.330

View more
  1 in total

1.  Precision Treatments in Epilepsy.

Authors:  Scott Demarest; Amy Brooks-Kayal
Journal:  Neurotherapeutics       Date:  2021-10-26       Impact factor: 6.088

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.